US5891685A
(en)
*
|
1996-06-03 |
1999-04-06 |
Mitsubishi Chemical Corporation |
Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid
|
KR100506134B1
(ko)
|
1997-02-07 |
2005-08-08 |
카네카 코포레이션 |
신규한 카르보닐 환원효소 및 이것을 코딩하는 유전자 및 이러한 환원효소 및 유전자 이용방법
|
KR20010033541A
(ko)
*
|
1997-12-25 |
2001-04-25 |
나가타 코이치 |
신규 미생물 및 그것을 사용한 폴리올의 제조방법
|
JP4012299B2
(ja)
*
|
1998-02-25 |
2007-11-21 |
ダイセル化学工業株式会社 |
ハロゲン置換を含む光学活性アルコールの製造方法
|
KR100461561B1
(ko)
*
|
1998-07-24 |
2005-04-06 |
삼성정밀화학 주식회사 |
(s)-3-카르복시-4-브로모부티르산의 제조방법
|
GB0011120D0
(en)
*
|
2000-05-09 |
2000-06-28 |
Avecia Ltd |
Process
|
US7132267B2
(en)
|
2002-08-09 |
2006-11-07 |
Codexis, Inc. |
Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters
|
MXPA05001537A
(es)
*
|
2002-08-09 |
2005-11-17 |
Codexis Inc |
Procesos enzimaticos para la produccion de derivados de acido 4-sustituido 3-hidroxibutirico.
|
KR101520209B1
(ko)
|
2003-11-06 |
2015-05-13 |
시애틀 지네틱스, 인크. |
리간드에 접합될 수 있는 모노메틸발린 화합물
|
BRPI0510883B8
(pt)
|
2004-06-01 |
2021-05-25 |
Genentech Inc |
composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
|
ES2579805T3
(es)
|
2004-09-23 |
2016-08-16 |
Genentech, Inc. |
Anticuerpos y conjugados modificados por ingeniería genética con cisteína
|
AU2005332660A1
(en)
|
2004-11-12 |
2006-12-14 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the N terminus
|
EP2722051B1
(en)
|
2005-07-07 |
2018-11-07 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus
|
US8871720B2
(en)
*
|
2005-07-07 |
2014-10-28 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
|
WO2008042876A2
(en)
|
2006-10-02 |
2008-04-10 |
Codexis, Inc. |
Compositions and methods for producing stereoisomerically pure statins and synthetic intermediates therefor
|
ES2544082T3
(es)
|
2006-12-07 |
2015-08-27 |
F. Hoffmann-La Roche Ag |
Compuestos inhibidores de fosfoinosítido 3-quinasa y métodos de uso
|
EP2115130B1
(en)
*
|
2007-02-08 |
2011-08-03 |
Codexis, Inc. |
Ketoreductases and uses thereof
|
PE20090481A1
(es)
|
2007-07-16 |
2009-05-18 |
Genentech Inc |
Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso
|
CN111499748A
(zh)
|
2007-07-16 |
2020-08-07 |
健泰科生物技术公司 |
抗cd79b抗体和免疫偶联物及使用方法
|
US7977078B2
(en)
|
2007-08-24 |
2011-07-12 |
Codexis, Inc. |
Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
|
KR101586503B1
(ko)
|
2007-09-13 |
2016-01-18 |
코덱시스, 인코포레이티드 |
아세토페논의 환원을 위한 케토리덕타제 폴리펩티드
|
EP2207781B1
(en)
|
2007-09-24 |
2012-11-28 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
CN101889081B
(zh)
|
2007-09-28 |
2014-06-18 |
科德克希思公司 |
酮还原酶多肽及其用途
|
WO2009046153A1
(en)
*
|
2007-10-01 |
2009-04-09 |
Codexis, Inc. |
Ketoreductase polypeptides for the production of azetidinone
|
EP3269737B1
(en)
|
2008-01-31 |
2024-06-19 |
Genentech, Inc. |
Anti-cd79b antibodies and immunoconjugates and methods of use
|
TWI527593B
(zh)
|
2008-03-18 |
2016-04-01 |
建南德克公司 |
抗her2抗體-藥物結合物及化療劑之組合及使用方法
|
WO2009117531A1
(en)
|
2008-03-18 |
2009-09-24 |
Seattle Genetics, Inc. |
Auristatin drug linker conjugates
|
AU2009270988A1
(en)
|
2008-07-15 |
2010-01-21 |
Genentech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
WO2010025287A2
(en)
*
|
2008-08-27 |
2010-03-04 |
Codexis, Inc. |
Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
|
US8426178B2
(en)
*
|
2008-08-27 |
2013-04-23 |
Codexis, Inc. |
Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
|
US8288131B2
(en)
*
|
2008-08-27 |
2012-10-16 |
Codexis, Inc. |
Ketoreductase polypeptides and uses thereof
|
SI2329014T1
(sl)
|
2008-08-29 |
2015-01-30 |
Codexis, Inc. |
Polipeptidi ketoreduktaze za stereoselektivno produkcijo (4s)-3(5s)-5(4-fluorofenil)-5-hidroksipentanoil)-4-fenil-1,3-oksazolidin -2-ona
|
CN102369011A
(zh)
|
2009-03-12 |
2012-03-07 |
健泰科生物技术公司 |
用于治疗造血恶性肿瘤的磷酸肌醇3-激酶抑制剂化合物与化学治疗剂的组合
|
JP6132548B2
(ja)
|
2009-04-01 |
2017-05-24 |
ジェネンテック, インコーポレイテッド |
抗FcRH5抗体および免疫接合体および使用方法
|
CN102482648B
(zh)
|
2009-06-22 |
2014-12-10 |
科德克希思公司 |
酮还原酶介导的产生α氯代醇的立体选择性途径
|
EP2448966B1
(en)
|
2009-07-03 |
2018-11-14 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
WO2011022548A2
(en)
|
2009-08-19 |
2011-02-24 |
Codexis, Inc. |
Ketoreductase polypeptides for the preparation of phenylephrine
|
JP5567136B2
(ja)
|
2009-09-08 |
2014-08-06 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
4−置換ピリジン−3−イル−カルボキサミド化合物及び使用方法
|
RS53164B
(en)
|
2009-09-28 |
2014-06-30 |
F. Hoffmann-La Roche Ag |
BENZOXAZEPINE PI3K INHIBITOR COMPOUNDS AND THEIR USE IN CANCER TREATMENT
|
SG10201407781SA
(en)
|
2009-09-28 |
2015-01-29 |
Hoffmann La Roche |
Benzoxepin PI3K Inhibitor Compounds And Methods Of Use
|
US10584181B2
(en)
|
2009-12-04 |
2020-03-10 |
Genentech, Inc. |
Methods of making and using multispecific antibody panels and antibody analog panels
|
SG181814A1
(en)
|
2009-12-23 |
2012-07-30 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them 2
|
US9080192B2
(en)
|
2010-02-10 |
2015-07-14 |
Codexis, Inc. |
Processes using amino acid dehydrogenases and ketoreductase-based cofactor regenerating system
|
ES2430567T3
(es)
|
2010-04-15 |
2013-11-21 |
Spirogen Sàrl |
Pirrolobenzodiacepinas y conjugados de las mismas
|
EP2566497B1
(en)
|
2010-05-04 |
2015-07-29 |
Codexis, Inc. |
Biocatalysts for ezetimibe synthesis
|
EP2579897A1
(en)
|
2010-06-08 |
2013-04-17 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
JP5889912B2
(ja)
|
2010-11-17 |
2016-03-22 |
ジェネンテック, インコーポレイテッド |
アラニニルメイタンシノール抗体コンジュゲート
|
EP2813506B1
(en)
|
2010-12-16 |
2016-05-25 |
F. Hoffmann-La Roche AG |
Tricyclic PI3K inhibitor compounds and methods of use
|
CA2831307A1
(en)
|
2011-03-30 |
2012-10-04 |
Arizona Board Of Regents, For And On Behalf Of, Arizona State Universi |
Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
|
JP6147246B2
(ja)
|
2011-04-01 |
2017-06-14 |
ジェネンテック, インコーポレイテッド |
Akt及びmek阻害剤化合物の組み合わせ、及び使用方法
|
EP2694072B1
(en)
|
2011-04-01 |
2017-11-29 |
Genentech, Inc. |
Combination of akt inhibitor compound and abiraterone for use in therapeutic treatments
|
EP2699597B1
(en)
|
2011-04-21 |
2016-06-01 |
Garvan Institute of Medical Research |
Modified variable domain molecules and methods for producing and using them b
|
DK2710018T3
(da)
|
2011-05-19 |
2022-03-21 |
Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio |
Makrocykliske forbindelser som proteinkinasehæmmere
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
PT2750713E
(pt)
|
2011-10-14 |
2016-01-20 |
Genentech Inc |
Pirrolobenzodiazepinas e conjugados das mesmas
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
WO2013067277A1
(en)
|
2011-11-03 |
2013-05-10 |
Genentech, Inc. |
Alkylated piperazine compounds as inhibitors of btk activity
|
KR101696525B1
(ko)
|
2011-11-03 |
2017-01-13 |
에프. 호프만-라 로슈 아게 |
Btk 활성 억제제로서의 8-플루오로프탈라진-1(2h)-온 화합물
|
ES2552514T3
(es)
|
2011-11-03 |
2015-11-30 |
Hoffmann-La Roche Ag |
Compuestos bicíclicos de piperazina
|
WO2013074650A1
(en)
|
2011-11-18 |
2013-05-23 |
Codexis, Inc. |
Biocatalysts for the preparation of hydroxy substituted carbamates
|
AU2013273489B9
(en)
|
2012-06-08 |
2018-08-23 |
F. Hoffmann-La Roche Ag |
Mutant selectivity and combinations of a phosphoinositide 3 Kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
DE102012017026A1
(de)
|
2012-08-28 |
2014-03-06 |
Forschungszentrum Jülich GmbH |
Sensor für NADP(H) und Entwicklung von Alkoholdehydrogenasen
|
US9346817B2
(en)
|
2012-08-30 |
2016-05-24 |
Genentech, Inc. |
Dioxino- and oxazin-[2,3-D]pyrimidine PI3K inhibitor compounds and methods of use
|
SI2906253T1
(sl)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin-protitelo proti PSMA
|
US10695433B2
(en)
|
2012-10-12 |
2020-06-30 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
AU2013328623B8
(en)
|
2012-10-12 |
2017-06-15 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
ES2649990T3
(es)
|
2012-10-12 |
2018-01-16 |
Medimmune Limited |
Conjugados de anticuerpos anti-CD22-pirrolobenzodiazepinas
|
CN110256469B
(zh)
|
2012-10-12 |
2022-05-17 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其结合物
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
CA2885305C
(en)
|
2012-10-12 |
2019-11-12 |
Spirogen Sarl |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
ES2530968T3
(es)
|
2012-10-12 |
2015-03-09 |
Spirogen Sarl |
Pirrolobenzodiazepinas y conjugados de las mismas
|
NZ707543A
(en)
|
2012-10-12 |
2018-09-28 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
CA2894961C
(en)
|
2012-12-21 |
2020-09-15 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
CN105247072B
(zh)
|
2013-02-25 |
2019-10-15 |
基因泰克公司 |
检测和治疗抗药性akt突变体的方法和组合物
|
AU2014229529B2
(en)
|
2013-03-13 |
2018-02-15 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
CN105209077B
(zh)
|
2013-03-13 |
2019-06-11 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓以及其结合物
|
CA2901941C
(en)
|
2013-03-13 |
2020-04-07 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
KR101876172B1
(ko)
|
2013-04-17 |
2018-07-10 |
카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 |
케톤의 거울상 이성질체 선택적 환원을 위한 디자이너 세포 및 거울상 이성질체 풍부한 알콜의 효율적인 생산에서의 이의 용도
|
CN105358545A
(zh)
|
2013-07-03 |
2016-02-24 |
豪夫迈·罗氏有限公司 |
杂芳基吡啶酮和氮杂-吡啶酮酰胺化合物
|
EP3033111B1
(en)
|
2013-08-12 |
2019-03-13 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
WO2015052532A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
WO2015082583A1
(en)
|
2013-12-05 |
2015-06-11 |
F. Hoffmann-La Roche Ag |
Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
|
MX2016007578A
(es)
|
2013-12-16 |
2016-10-03 |
Genentech Inc |
Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo [e] indol, y metodos de uso y tratamiento.
|
US9133488B2
(en)
|
2013-12-30 |
2015-09-15 |
University Of Alaska Fairbanks |
Synthetic methods and compounds related thereto
|
US20150258080A1
(en)
|
2014-03-13 |
2015-09-17 |
Genentech, Inc. |
Therapeutic combinations with estrogen receptor modulators
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
CN106687141A
(zh)
|
2014-09-10 |
2017-05-17 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓及其缀合物
|
AR101844A1
(es)
|
2014-09-12 |
2017-01-18 |
Genentech Inc |
Anticuerpos y conjugados modificados genéticamente con cisteína
|
CN106714844B
(zh)
|
2014-09-12 |
2022-08-05 |
基因泰克公司 |
蒽环类二硫化物中间体、抗体-药物缀合物和方法
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
EP3194400A1
(en)
|
2014-09-17 |
2017-07-26 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
JP6507234B2
(ja)
|
2014-10-02 |
2019-04-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ブルトンチロシンキナーゼ(btk)によって介入される障害の処置における使用のためのピラゾールカルボキサミド化合物
|
CA2968447A1
(en)
|
2014-11-25 |
2016-06-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates and their use to treat neoplasms
|
ES2830725T3
(es)
|
2015-02-10 |
2021-06-04 |
Codexis Inc |
Polipéptidos cetoreductasa para la síntesis de compuestos quirales
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
PL3341376T3
(pl)
|
2015-08-26 |
2021-08-02 |
Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Skondensowane związki tricykliczne jako inhibitory kinaz białkowych
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
US10973786B2
(en)
|
2016-03-11 |
2021-04-13 |
Axcess Global Sciences, Llc |
R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
|
US11185518B2
(en)
|
2017-12-19 |
2021-11-30 |
Axcess Global Sciences, Llc |
S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
|
US10596131B2
(en)
|
2017-11-22 |
2020-03-24 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
US10245243B1
(en)
|
2017-12-19 |
2019-04-02 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
|
US10973792B2
(en)
|
2019-02-13 |
2021-04-13 |
Axcess Global Sciences, Llc |
Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
|
US10245242B1
(en)
*
|
2017-11-22 |
2019-04-02 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
US10736861B2
(en)
|
2016-03-11 |
2020-08-11 |
Axcess Global Sciences, Llc |
Mixed salt compositions for producing elevated and sustained ketosis
|
US11103470B2
(en)
|
2017-11-22 |
2021-08-31 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
US10596130B2
(en)
|
2017-12-19 |
2020-03-24 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
|
US10596129B2
(en)
|
2017-11-22 |
2020-03-24 |
Axcess Global Sciences, Llc |
Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
|
US11241403B2
(en)
|
2016-03-11 |
2022-02-08 |
Axcess Global Sciences, Llc |
Beta-hydroxybutyrate mixed salt compositions and methods of use
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
WO2017201132A2
(en)
|
2016-05-18 |
2017-11-23 |
Mersana Therapeutics, Inc. |
Pyrrolobenzodiazepines and conjugates thereof
|
JP7043425B2
(ja)
|
2016-06-06 |
2022-03-29 |
ジェネンテック, インコーポレイテッド |
シルベストロール抗体-薬物コンジュゲート及び使用方法
|
CN109641910A
(zh)
|
2016-06-24 |
2019-04-16 |
梅尔莎纳医疗公司 |
吡咯并苯二氮*及其缀合物
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
AU2018217926B2
(en)
|
2017-02-08 |
2019-10-03 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
RS62343B1
(sr)
|
2017-02-08 |
2021-10-29 |
Adc Therapeutics Sa |
Pirolobenzodiazepin-antitelo konjugati
|
JP2020517609A
(ja)
|
2017-04-18 |
2020-06-18 |
メディミューン リミテッド |
ピロロベンゾジアゼピン複合体
|
EP3612234B1
(en)
|
2017-04-20 |
2024-03-13 |
ADC Therapeutics SA |
Combination therapy with an anti-axl antibody-drug conjugate
|
CN110831618B
(zh)
|
2017-04-27 |
2023-08-25 |
科德克希思公司 |
酮还原酶多肽及多核苷酸
|
US11318211B2
(en)
|
2017-06-14 |
2022-05-03 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-CD19 ADC
|
SI3668874T1
(sl)
|
2017-08-18 |
2022-04-29 |
Medimmune Limited |
Pirolobenzodiazepinski konjugati
|
US20200216463A1
(en)
|
2017-09-20 |
2020-07-09 |
Ph Pharma Co., Ltd. |
Thailanstatin analogs
|
US11202769B2
(en)
|
2017-11-22 |
2021-12-21 |
Axcess Global Sciences, Llc |
Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
|
US10925843B2
(en)
|
2018-04-18 |
2021-02-23 |
Axcess Global Sciences, Llc |
Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
|
US11944598B2
(en)
|
2017-12-19 |
2024-04-02 |
Axcess Global Sciences, Llc |
Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
US11806324B2
(en)
|
2018-04-18 |
2023-11-07 |
Axcess Global Sciences, Llc |
Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
|
US11129802B2
(en)
|
2018-08-27 |
2021-09-28 |
Axcess Global Sciences, Llc |
Compositions and methods for delivering cannabidiol and ketone bodies
|
US10980772B2
(en)
|
2018-08-27 |
2021-04-20 |
Axcess Global Sciences, Llc |
Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
|
US11241401B2
(en)
|
2020-02-06 |
2022-02-08 |
Axcess Global Sciences, Llc |
Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
|
US11419836B2
(en)
|
2019-02-13 |
2022-08-23 |
Axcess Global Sciences, Llc |
Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
|
ES2975412T3
(es)
|
2018-06-21 |
2024-07-05 |
Fis Fabbrica Italiana Sintetici Spa |
Proceso enzimático para la preparación de droxidopa
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
US11950616B2
(en)
|
2019-06-21 |
2024-04-09 |
Axcess Global Sciences, Llc |
Non-vasoconstricting energy-promoting compositions containing ketone bodies
|
US11033553B2
(en)
|
2019-06-21 |
2021-06-15 |
Axcess Global Sciences, Llc |
Non-vasoconstricting energy-promoting compositions containing ketone bodies
|
CA3214802A1
(en)
|
2021-04-02 |
2022-10-06 |
Genentech, Inc. |
Processes for making bicyclic ketone compounds
|
WO2024138128A2
(en)
|
2022-12-23 |
2024-06-27 |
Genentech, Inc. |
Cereblon degrader conjugates, and uses thereof
|
WO2024150146A1
(en)
|
2023-01-12 |
2024-07-18 |
Novartis Ag |
Engineered ketoreductase polypeptides
|
US11969430B1
(en)
|
2023-03-10 |
2024-04-30 |
Axcess Global Sciences, Llc |
Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
|